Drug Type Small molecule drug |
Synonyms 17i |
Target |
Mechanism HBV capsid inhibitors(HBV capsid inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H19F2N3OS |
InChIKeyBPRUTWSXZJFFDR-UHFFFAOYSA-N |
CAS Registry2955574-79-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | CN | 15 Oct 2023 |